Michael Rawlinson QC has written a paper about awards for immunotherapy treatment in mesothelioma claims. In particular, he writes about the different forms such awards can take, having acted in two cases which settled last week in which the awards were compromised on different bases: one in the form of a variable PPO, and the other as a ‘float’ agreement. The paper can be read here.
Regular readers of this blog will recall that Michael has previously written about this topic. For those that missed it, the post can be viewed here.